VS
iShares Global Healthcare Index ETF (XHC) and Evolve Global Healthcare Enhanced Yield ETF (LIFE) offer distinct profiles for Canadian ETF investors. A direct comparison shows that XHC focuses its top 3 sector exposures on Healthcare, Consumer Non-Cyclicals, and Consumer Cyclicals, while LIFE leans towards Healthcare. When evaluating costs, XHC features a management fee (MER) of 0.63%, compared to 0.45% for LIFE. Performance-wise, XHC has returned 6.07% year-to-date with -$47 M in net flows, whereas LIFE is at 0.28% with +$27 M. Use the comparison tool below to benchmark these funds across top 10 holdings, yield, sector weights and historical returns.
NAV Performance and Flows
Key Data
Compare
XHC
LIFE
| AuM | $541.04 M | $271.30 M |
| Management Fees | 0.63% | 0.45% |
| Exp. ratio | 0.66% | 0.65% |
| Tracking Difference | -0.81% | - |
Historical performance and flows
As of July 29, 2026
| 1M | 3M | YTD | 1Y | 3Y | ||
|---|---|---|---|---|---|---|
| Perf. | XHC | +2.96% | +14.36% | +6.07% | +20.22% | +20.11% |
LIFE | +3.05% | +10.62% | +0.28% | +8.91% | +3.04% | |
| Flows | XHC | +$11 M | -$6 M | -$47 M | -$10 M | -$91 M |
LIFE | +$1 M | +$7 M | +$27 M | +$64 M | +$102 M |
XHC vs LIFE exposure
Countries
XHC
USA
69.39%
Switzerland
10.35%
Other
20.26%
LIFE
USA
66.45%
Switzerland
10.21%
United Kingdom
9.14%
Other
14.20%
Sectors
XHC
Healthcare
96.86%
LIFE
Healthcare
101.40%
As of July 29, 2026
Top 10 Holdings
XHC
Eli Lilly & Co.
10.91%
Johnson & Johnson
7.03%
AbbVie, Inc.
5.11%
UnitedHealth Group, Inc.
4.39%
Merck & Co., Inc.
4.11%
AstraZeneca PLC
3.76%
Roche Holding AG
3.75%
Novartis AG
3.72%
Amgen, Inc.
2.53%
Thermo Fisher Scientific, Inc.
2.41%
LIFE
Novo Nordisk A/S
6.45%
Eli Lilly & Co.
6.41%
AbbVie, Inc.
6.18%
Johnson & Johnson
5.44%
Merck & Co., Inc.
5.29%
Amgen, Inc.
5.19%
Novartis AG
5.11%
Roche Holding AG
5.11%
Danaher Corp.
5.10%
Thermo Fisher Scientific, Inc.
5.07%
Diversification
XHC
Total weight of top 10 holdings out of 111 total
47.72%
LIFE
Total weight of top 10 holdings out of 20 total
55.34%
Characteristics
Compare
XHC
LIFE
| Provider | iShares | Evolve ETFs |
| Management | Passively managed | Actively managed |
| Benchmark | S&P Global 1200 Health Care CAD Hedged Net Total Return Index - CAD | - |
| Replication Method | ||
| Asset Class | Equity | Equity |
| Dividend Policy | Distributing | Distributing |
| Trailing 12m distribution yield | 1.82% | 11.52% |
| Meets ESG criteria | No | No |
| Inception Date | April 12, 2011 | October 25, 2017 |
Frequently asked questions about XHC and LIFE
Which ETF has performed better year to date: XHC or LIFE?
As of July 29, 2026, XHC has returned 6.07% year to date, while LIFE has returned 0.28%. XHC is ahead on YTD performance.
Which ETF is larger by assets under management: XHC or LIFE?
As of July 29, 2026, XHC manages $541.04 M in assets, while LIFE manages $271.30 M. XHC is the larger fund by AUM.
How are XHC and LIFE managed?
XHC is passively managed by iShares. It tracks the S&P Global 1200 Health Care CAD Hedged Net Total Return Index - CAD benchmark. LIFE is actively managed by Evolve ETFs. It does not track an index.
What sectors do XHC and LIFE emphasize?
XHC is most exposed to Healthcare, Consumer Non-Cyclicals, and Consumer Cyclicals. LIFE is most exposed to Healthcare.
Which ETF is attracting more investor flows: XHC or LIFE?
Year to date, XHC has seen -$47.21 M in net flows, compared with +$26.76 M for LIFE. LIFE has attracted more net investor money so far.
How do the fees of XHC and LIFE compare?
XHC has an expense ratio of 0.66%, while LIFE has an expense ratio of 0.65%.
What are the top holdings of XHC and LIFE?
XHC's largest holdings include Eli Lilly & Co., Johnson & Johnson, and AbbVie, Inc.. LIFE's top holdings include Novo Nordisk A/S, Eli Lilly & Co., and AbbVie, Inc..
Which ETF is more diversified: XHC or LIFE?
XHC holds 110 securities, while LIFE holds 20. On holdings count, XHC is the more diversified portfolio.
Recent articles about XHC and LIFE
The ETF Market Canada is brought to you by Cboe in partnership with Trackinsight SA who is providing all the data, analysis and editorial content on this site. Unless explicitly stated as such, any information that you receive is not real-time.
All content on the ETF Market Canada is for your general information use only, Cboe is not responsible for any use of content by you outside this scope. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by Cboe and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
All content on the ETF Market Canada is for your general information use only, Cboe is not responsible for any use of content by you outside this scope. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by Cboe and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.